Loading organizations...

§ Private Profile · San Francisco, CA, USA
AI clinician assistant automates clinical documentation for healthcare providers, generating specialty-aware notes and summaries.
Freed has raised $37.2M across 2 funding rounds.
Key people at Freed.
Freed was founded in 2023 by Erez Druk (Founder).
Freed has raised $37.2M in total across 2 funding rounds.
Freed is a healthcare technology company based in an undisclosed location that develops an artificial intelligence clinician assistant to automate medical documentation by listening to patient encounters in real time. The platform utilizes clinical-specific speech recognition and large language models to generate specialty-aware notes, medical codes, and patient instructions while maintaining compliance with HIPAA, SOC2, and HITECH standards. Operating on a software as a service business model with subscription plans priced up to $119 per month, the application is currently utilized by more than 26,000 clinicians across both in-person and telehealth settings. Backed by lead investor Sequoia Capital, the enterprise is expanding its product suite beyond core scribing capabilities to include automated front desk reception and revenue cycle management tools. Freed was originally founded in 2023 by a clinician named Gabi and her spouse.
Freed has raised $37.2M across 2 funding rounds. Most recently, it raised $30.0M Series A in March 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 1, 2025 | $30M Series A | Sequoia Capital | Array Ventures, AV8 Ventures, BoxGroup, C2 Investment, Jenny Fielding, Scott Hartley, FirstHand Alliance, General Catalyst, Greycroft, Harrison Metal, Investo, Next Play Ventures, Plug & Play Ventures, Susa Ventures, True Ventures, UpHonest Capital, Xfund, Y Combinator, Patrick S. Chung, Scott Belsky, Steve Norall | Announced |
| Mar 18, 2024 | $7.2M Series A | Bhushan Patil, Sanjay Nayar | Piper Serica | Announced |
Freed was founded in 2023 by Erez Druk (Founder).
Freed has raised $37.2M in total across 2 funding rounds.
Freed's investors include Sequoia Capital, Array Ventures, AV8 Ventures, BoxGroup, C2 Investment, Jenny Fielding, Scott Hartley, FirstHand Alliance, General Catalyst, Greycroft, Harrison Metal, Investo.
Key people at Freed.
Freed is an AI-powered clinician assistant that automates visit preparation, clinical documentation, and electronic health record (EHR) interactions, significantly reducing the administrative burden on healthcare providers. Its core product is an ambient AI scribe that listens to clinician-patient conversations, transcribes them, and generates structured clinical notes such as SOAP notes, which clinicians can review and edit. Freed primarily serves small to medium-sized independent practices and solo clinicians across nearly 100 specialties, including mental health and pediatrics. By saving clinicians an estimated two to three hours daily, Freed addresses the critical problem of clinician burnout caused by excessive documentation, enabling doctors to focus more on patient care and achieve better work-life balance. The company has demonstrated strong growth, reaching over 20,000 paying users and surpassing $20 million in annual recurring revenue within two years of its 2023 founding[1][2][4].
Freed was founded in 2023 by Erez Druk, an engineer formerly at Facebook, and Andrey Bannikov, inspired by Druk’s wife, Dr. Gabi Meckler, a practicing clinician frustrated by the time-consuming paperwork that detracted from patient care. The founders designed Freed as a personal AI assistant to free clinicians from administrative overload. The idea emerged from a real-world need to improve clinicians’ daily workflow and quality of life. Early traction came from a product-led growth approach targeting the underserved “long tail” of healthcare providers—small clinics and solo practitioners—who lacked access to efficient, affordable documentation tools. This focus allowed Freed to build a loyal user base quickly and scale effectively[1][2].
Freed rides the wave of AI adoption in healthcare, particularly the trend toward automating clinical documentation to combat physician burnout—a major systemic issue. The timing is critical as healthcare providers face increasing administrative demands and seek digital tools that improve efficiency without compromising care quality. Freed’s focus on small and medium practices fills a gap often overlooked by large health tech vendors. The emergence of free AI scribes from large platforms like Doximity introduces competitive pressure, but Freed’s emphasis on superior quality, personalization, and clinician trust positions it to maintain differentiation. Its development of industry-wide quality benchmarks could set new standards in AI medical scribing, influencing the broader ecosystem[1][4].
Freed is poised to continue expanding its user base and product capabilities, potentially deepening integrations with EHRs and adding AI features that further streamline clinical workflows. The competitive landscape will intensify as free or low-cost AI scribes emerge, but Freed’s premium, clinician-focused approach and personalization may sustain its growth and loyalty. Future trends shaping Freed’s journey include broader AI acceptance in healthcare, regulatory developments around AI in medicine, and increasing demand for multilingual and specialty-specific solutions. Freed’s mission to make clinicians happier by reclaiming their time aligns with a growing movement to humanize healthcare through technology, suggesting its influence will expand as it matures[1][2][4][5].